Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanate vs amoxicillin-clavulanate + ciprofloxacin in low-risk febrile neutropenia
2020-003159-13Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Jul 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chemotherapy-induced neutropenia (CIN), febrile neutropenia (FN) and cancer comparing Amoxicillin-clavulanate monotherapy with Amoxicillin-clavulanate + ciprofloxacin combination (2 arms). Primary endpoint: Antibiotic therapy success rate. Started Jul 2020; status: completed.
02
Drugs
amoxicillin + clavulanateciprofloxacin
03
Conditions
chemotherapy-induced neutropenia (CIN)febrile neutropenia (FN)cancer
Beyond the preview
Go deeper on 2020-003159-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003159-13.